Iván Hernández Dalas: MMI earns FDA clearance for robotic soft tissue dissection tools
Medical Microinstruments (MMI) has received U.S. Food and Drug Administration 510(k) clearance for its NanoWrist Scissors and Forceps. These instruments are used for soft tissue dissection, allowing MMI’s Symani Surgical System to handle critical steps in complex surgeries. Surgeons at Tampa General Hospital, which has an established microsurgical robotics program, completed the first U.S. clinical case of the cleared instruments. Surgeons used MMI’s instruments to complete a lymphovenous bypass (LVB) procedure. Symani assisted in the procedure from initial incision to skin closure. “As we continue to evolve Symani, the first dissection instruments are a critical step in that mission,” said Mark Toland, CEO of MMI. “The addition of these capabilities to our platform is game-changing in supermicrosurgical procedures where extreme precision for the smallest vessels is essential. We will continue to develop technologies that advance the future of microsurgery with Symani an...